Although it did not reach statistical significance, the direction of effect was consistent: studies without background medications tended to report larger glycemic improvements (e.g., FBG: β = 0.96, 95% CI −0.10 to 2.01, p = 0.076).
← all excerpts
The impact of Jinlida on blood glucose control and insulin resistance in patients with prediabetes and type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.
1
—
—